• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , Jan. 17

PARENTERAL Drugs (India) Ltd plans to set up two manufacturing facilities for drugs and pharmaceuticals in Himachal Pradesh and Andhra Pradesh.

While the first plant would be set up in Himachal Pradesh, the second plant would be in Andhra Pradesh, the company informed the BSE on Saturday.

It expects to end the current fiscal, ending March 2004, with a turnover of Rs 175 crore. It also targets sales of Rs 500 crore by 2008, following the commissioning of the two new plants.

With its research and development activities under way, the company is also in the advance stage of clinical trials for its new product, continuous ambulatory peritoneal dialysis (CAPD), for an economical dialysis. The current year has also seen the company focus its attention on the eastern region of the country, through its new base in Kolkata.

More Stories on : New Projects | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Cadila Pharma likely to acquire US co

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line